Literature DB >> 22980294

A proposal for new clinical concepts in the management of atrial fibrillation.

A John Camm1, Sana M Al-Khatib, Hugh Calkins, Jonathan L Halperin, Paulus Kirchhof, Gregory Y H Lip, Stanley Nattel, Jeremy Ruskin, Amitava Banerjee, Dan Blendea, Eduard Guasch, Matthew Needleman, Irina Savelieva, Juan Viles-Gonzalez, Eric S Williams.   

Abstract

Atrial fibrillation (AF) represents a growing public health burden. It is a complex condition, involving a number of etiologic factors and arrhythmia mechanisms associated with atrial remodeling. Greater understanding of these mechanisms may improve therapy. Current AF classification schemes are limited by simplicity. A number of risk factors predict AF onset, and additional factors are being evaluated in registry studies. Doppler imaging and Holter monitoring in high-risk patients to predict the onset of AF and progression from paroxysmal to permanent AF are promising. There is a need for a novel multifactorial classification model encompassing AF duration, symptoms, markers of atrial remodeling, and a risk score for AF onset, persistence, progression, and complications to guide treatment and prognostication. Preventing AF onset with upstream therapy is of great interest, but current data are conflicting. More study is needed to optimize rhythm control with antiarrhythmic drugs and targeted ablation to specific patient populations at an earlier stage. There is little consensus on optimal rate control and no information relating to optimum rate control in specific populations. This article highlights new concepts in AF and directions for future research.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22980294     DOI: 10.1016/j.ahj.2012.05.017

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  19 in total

1.  Why we Should Not Delay Ablation in New Onset Recurrent Atrial Fibrillation.

Authors:  Paramdeep S Dhillon; Riyaz Kaba; David E Ward
Journal:  J Atr Fibrillation       Date:  2013-04-06

2.  Beta-blockers or Digoxin for Atrial Fibrillation and Heart Failure?

Authors:  Laurent Fauchier; Guillaume Laborie; Nicolas Clementy; Dominique Babuty
Journal:  Card Fail Rev       Date:  2016-05

Review 3.  Inflammation and C-reactive protein in atrial fibrillation: cause or effect?

Authors:  Roberto Galea; Maria Teresa Cardillo; Annalisa Caroli; Maria Giulia Marini; Chiara Sonnino; Maria L Narducci; Luigi M Biasucci
Journal:  Tex Heart Inst J       Date:  2014-10-01

4.  Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry.

Authors:  Jelena Kornej; Jedrzej Kosiuk; Gerhard Hindricks; Arash Arya; Philipp Sommer; Sascha Rolf; Daniela Husser; Gregory Y H Lip; Andreas Bollmann
Journal:  Clin Res Cardiol       Date:  2015-02-24       Impact factor: 5.460

Review 5.  Atrial fibrillation: mechanisms, therapeutics, and future directions.

Authors:  Jason Pellman; Farah Sheikh
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

6.  A new mechanism links preamyloid oligomer formation in the myocyte stress response associated with atrial fibrillation.

Authors:  Jason Pellman; Farah Sheikh
Journal:  J Mol Cell Cardiol       Date:  2014-12-23       Impact factor: 5.000

7.  Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation.

Authors:  Osman Sonmez; Furkan U Ertem; Mehmet Akif Vatankulu; Ercan Erdogan; Abdurrahman Tasal; Sıtkı Kucukbuzcu; Omer Goktekin
Journal:  Med Sci Monit       Date:  2014-03-21

Review 8.  The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis.

Authors:  Jordi Heijman; Vincent Algalarrondo; Niels Voigt; Jonathan Melka; Xander H T Wehrens; Dobromir Dobrev; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2015-12-23       Impact factor: 10.787

9.  Seasonal Variation in Paroxysmal Atrial Fibrillation: A Systematic Review.

Authors:  Rohit S Loomba
Journal:  J Atr Fibrillation       Date:  2015-02-28

Review 10.  Atrial remodelling in atrial fibrillation: CaMKII as a nodal proarrhythmic signal.

Authors:  Olurotimi O Mesubi; Mark E Anderson
Journal:  Cardiovasc Res       Date:  2016-01-13       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.